Abbreviated MBCT for Depression in Older Black or African American Breast Cancer Survivors (NCT06336538) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Abbreviated MBCT for Depression in Older Black or African American Breast Cancer Survivors
United States23 participantsStarted 2025-03-21
Plain-language summary
The purpose of this research study is to develop and test an intervention designed to improve mood and reduce symptoms of depression.
Who can participate
Age range65 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* ≥65 years old
* fluency in English
* female
* African American/Black
* diagnosis of Stage I, II or III breast cancer
* at least 3 months past active treatment for cancer (chemotherapy, surgery and/or radiation therapy) with no additional treatment scheduled except endocrine therapy
* mild to moderate symptoms of depression (Patient Health Questionnaire-9(26) scores 4-14)
* willing to be audio and video-recorded
* willing to provide written informed consent.
Exclusion Criteria:
* moderately severe or severe depression (PHQ-9 scores ≥15)
* comorbid psychiatric illness or other psychological disorders that would interfere with the ability to participate in or receive benefit from MBCT-Brief, including generalized social anxiety disorder, panic disorder, post-traumatic stress disorder, obsessive-compulsive disorder, drug abuse or dependence, bipolar disorder, borderline personality disorder, and active suicidal ideation.
* changes in antidepressant medication within 6 weeks of intake
* prior history of engaging in formal MBIs including Mindfulness-Based Stress Reduction, MBCT, Acceptance and Commitment Therapy, Dialectical Behavior Therapy
* current daily meditation practice